Andreas Wree Selected Research

Oxidopamine (6 Hydroxydopamine)

1/2022	Transmembrane protein 119 is neither a specific nor a reliable marker for microglia.
1/2022	Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.
1/2021	Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.
5/2018	Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse.
1/2017	Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.
4/2016	Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease.
1/2016	Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease.
2/2011	Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.
12/2008	Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Wree Research Topics

Disease

16	Parkinson Disease (Parkinson's Disease) 01/2022 - 07/2004
8	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 03/2021 - 01/2011
7	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2014 - 01/2003
5	Glaucoma 01/2018 - 07/2012
4	Inflammation (Inflammations) 06/2019 - 01/2013
3	Gliosis 01/2018 - 04/2004
3	Fibrosis (Cirrhosis) 01/2017 - 07/2012
3	Infections 12/2014 - 11/2007
2	Multiple Sclerosis 01/2022 - 12/2006
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 12/2006
2	Wounds and Injuries (Trauma) 10/2021 - 12/2011
2	Neoplasms (Cancer) 10/2021 - 06/2020
2	Reperfusion Injury 05/2018 - 01/2013
2	Hypoxia (Hypoxemia) 07/2017 - 12/2010
2	Ganglion Cysts (Ganglion) 11/2014 - 08/2010
2	Keratoconus 06/2011 - 02/2011
2	Huntington Disease (Huntington's Disease) 04/2004 - 01/2003
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022
1	Weight Loss (Weight Reduction) 02/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Paralysis (Palsy) 05/2018
1	Retrograde Degeneration 05/2018
1	Liver Diseases (Liver Disease) 03/2018
1	Niemann-Pick Diseases (Niemann Pick Disease) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Body Weight (Weight, Body) 11/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Neuroinflammatory Diseases 01/2016
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2015
1	Choroidal Effusions 06/2015
1	Retinal Degeneration 11/2014
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2014
1	Starvation 08/2014
1	Melanoma (Melanoma, Malignant) 06/2013
1	Heart Arrest (Cardiac Arrest) 01/2013
1	Neuralgia (Stump Neuralgia) 01/2013
1	Pain (Aches) 01/2013
1	Cognitive Dysfunction 09/2012
1	Cicatrix (Scar) 07/2012
1	Dementia (Dementias) 10/2011
1	Nausea 10/2011
1	Alzheimer Disease (Alzheimer's Disease) 10/2011
1	Vomiting 10/2011

Drug/Important Bio-Agent (IBA)

9	Oxidopamine (6 Hydroxydopamine)IBA 01/2022 - 12/2008
6	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 06/2013
6	LipidsIBA 09/2019 - 01/2013
5	Cholinergic Agents (Cholinergics)IBA 01/2020 - 02/2011
5	incobotulinumtoxinA FDA Link 05/2018 - 02/2011
4	CholesterolIBA 06/2019 - 01/2011
4	Pharmaceutical PreparationsIBA 01/2019 - 10/2011
3	miglustat (Zavesca)FDA Link 03/2021 - 11/2016
3	CollagenIBA 07/2012 - 06/2011
3	Peptides (Polypeptides)IBA 10/2011 - 12/2006
2	Botulinum Toxins (Botulinum Toxin)IBA 10/2021 - 02/2011
2	Pregnanolone (Allopregnanolone)IBA 03/2021 - 06/2019
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2017 - 08/2014
2	CytokinesIBA 01/2017 - 04/2016
2	Ciliary Neurotrophic Factor (CNTF)IBA 04/2004 - 01/2003
1	CuprizoneIBA 01/2022
1	NeurosteroidsIBA 03/2021
1	OligosaccharidesIBA 03/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	AcetoneIBA 05/2018
1	pentaneIBA 05/2018
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 05/2018
1	HexanesIBA 05/2018
1	pirfenidoneIBA 01/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016
1	PolymersIBA 09/2015
1	GlycolipidsIBA 11/2014
1	LipofuscinIBA 11/2014
1	tau Proteins (tau Protein)IBA 07/2014
1	Protein Kinases (Protein Kinase)IBA 07/2014
1	RutheniumIBA 06/2013
1	Glial Fibrillary Acidic ProteinIBA 06/2013
1	AntibodiesIBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Toll-Like Receptor 2IBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	CaspasesIBA 01/2013
1	Thiethylperazine (Thiethylperazine Malate)FDA Link 10/2011
1	Amyloid (Amyloid Fibrils)IBA 10/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2011
1	SterolsIBA 07/2011

Therapy/Procedure

10	Therapeutics 03/2021 - 01/2011
7	Injections 01/2022 - 12/2008
2	Lasers (Laser) 12/2011 - 07/2006
2	Transplantation 12/2006 - 09/2004
1	Subcutaneous Injections 06/2020
1	Euthanasia (Mercy Killing) 02/2020
1	Laparotomy 05/2018
1	Refractive Surgical Procedures 12/2014
1	Brachytherapy 06/2013
1	Ligation 01/2013
1	Cardiopulmonary Resuscitation (CPR) 01/2013
1	Glaucoma Drainage Implants 01/2013
1	Trabeculectomy (Trabeculoplasty) 07/2012